Furthermore, inhibition of a Hippo-pathway-related long noncoding RNA that interacts with mTORC1 subunit Raptor is associated with suppression of tumor growth, and YAP/TAZ-directed therapies have shown benefits in treating CCA patients with chromosomal instability (134, 135) (Table 2). Here, YAP1 is linked to cholangiocarcinoma.